Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIDOCRIT: IV Lidocaine for Postoperative Critical Care Comfort
NCT07043023Phase 4Not yet recruiting
- Sponsor
- CHU Rennes
- Start
- Oct 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Lidocaine with Placebo (2 arms). Primary endpoint: Inconfort of REAnimation Patients Score at Day 15. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
lidocaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07043023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07043023.